Parkinson's disease (PD) is one of the major neurodegenerative diseases (ND) which
presents a progressive neurodegeneration characterized by loss of dopamine in the …

Lithium, the long-standing hallmark treatment for bipolar disorder, has recently been
identified as a potential neuroprotective agent in neurodegeneration. Here we focus on …

Wnt signaling is required for neurogenesis, the fate of neural progenitors, the formation of
neuronal circuits during development, neuron positioning and polarization, axon and …

Neurodegeneration is a pathological process characterized by progressive neuronal
impairment, dysfunction, and loss due to mitochondrial dysfunction, oxidative stress …

Lithium is a well-established therapeutic option for the acute and long-term management of
bipolar disorder and major depression. More recently, based on findings from translational …

Parkinson's disease (PD) is a major neurodegenerative disease (ND), presenting a
progressive degeneration of the nervous system characterized by a loss of dopamine in the …

Lithium has been used for the treatment of bipolar disorder (BD) for the last sixty or more
years, and recent studies with more reliable designs and updated guidelines have …

The role of lithium as a possible therapeutic strategy for neurodegenerative diseases has
generated scientific interest. We systematically reviewed and meta-analyzed pre-clinical and …

Lithium has long been used for the treatment of psychiatric disorders, due to its robust
beneficial effect as a mood stabilizing drug. Lithium's effectiveness for improving …

Lithium is a monovalent cation that was introduced in 1949 by John Cade for the treatment
of bipolar disorder. Clinical reports and subsequent studies confirmed this application and …